| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 8.910 | 16.715 | 16.632 | 15.527 | 3.644 | 25.706 | 24.920 | 42.379 | 71.826 |
| Total Income - EUR | - | 8.910 | 16.715 | 16.632 | 15.527 | 3.644 | 25.731 | 24.924 | 42.379 | 71.826 |
| Total Expenses - EUR | - | 8.666 | 12.520 | 10.245 | 5.181 | 5.366 | 5.904 | 8.853 | 17.639 | 19.603 |
| Gross Profit/Loss - EUR | - | 244 | 4.195 | 6.387 | 10.346 | -1.723 | 19.827 | 16.071 | 24.741 | 52.224 |
| Net Profit/Loss - EUR | - | 65 | 4.026 | 6.101 | 9.881 | -1.808 | 19.258 | 15.595 | 24.415 | 50.069 |
| Employees | - | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Endopit Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 157 | 162 | 0 | 0 | 0 | 1.042 | 1.640 | 1.440 | 1.254 |
| Current Assets | - | 2.515 | 5.866 | 6.943 | 12.194 | 11.354 | 28.180 | 6.733 | 25.492 | 48.393 |
| Inventories | - | 117 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 835 | 985 | 750 | 71 | 0 | 456 | 1.353 | 238 | 3.808 |
| Cash | - | 1.563 | 4.881 | 6.193 | 12.123 | 11.354 | 27.724 | 5.380 | 25.254 | 44.585 |
| Shareholders Funds | - | 110 | 4.134 | 2.208 | 12.046 | 10.009 | 22.880 | 971 | 25.383 | 928 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.563 | 1.895 | 4.735 | 148 | 150 | 6.354 | 7.402 | 1.549 | 48.719 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 1.195 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Endopit Srl